Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HOLLER E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 105 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schulz, U; Munker, R; Ertl, B; Holler, E; Kolb, HJ
      Different types of human leukemias express the message for TNF-alpha and interleukin-10

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    2. Karrer, S; Holler, E; Szeimies, RM
      Cutaneous manifestations of graft-versus-host disease

      MEDIZINISCHE KLINIK
    3. Runde, V; Ross, S; Trenschel, R; Lagemann, E; Basu, O; Renzing-Kohler, K; Schaefer, UW; Roggendorf, M; Holler, E
      Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study

      BONE MARROW TRANSPLANTATION
    4. Sviland, L; Hromadnikova, I; Sedlacek, P; Cermakova, M; Stechova, K; Holler, E; Eissner, G; Schulz, U; Kolb, HJ; Jackson, G; Wang, XN; Dickinson, AM
      Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation

      HUMAN IMMUNOLOGY
    5. Padovan, CS; Gerbitz, A; Sostak, P; Holler, E; Ferrara, JLM; Bise, K; Straube, A
      Cerebral involvement in graft-versus-host disease after murine bone marrowtransplantation

      NEUROLOGY
    6. Einsele, H; Bertz, H; Beyer, J; Kiehl, MG; Runde, V; Kolb, HJ; Holler, E; Beck, R; Schwerdfeger, R; Schumacher, U; Hebart, H; Martin, H; Kienast, J; Ullmann, AJ; Maschmeyer, G; Kruger, W; Link, H; Schmidt, CA; Oettle, H; Klingebiel, T
      Reports of society meetings and consensus conferences

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    7. Schmid, C; Muth, A; Humann, M; Ledderose, G; Salat, C; Munker, R; Schleuning, M; Holler, E; Kolb, HJ
      Adoptive immunotherapy of acute leukemia and acute phase chronic myeloid leukemia after allogeneic bone marrow transplantation

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    8. Aebert, H; Kirchner, S; Keyser, A; Birnbaum, DE; Holler, E; Andreesen, R; Eissner, G
      Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    9. Hildebrandt, G; Holler, E; Woenkhaus, M; Quarch, G; Reichle, A; Schalke, B; Andreesen, R
      Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2mg of vincristine chemotherapy

      ANNALS OF ONCOLOGY
    10. Lee, BS; Holler, E
      beta-poly(L-malate) production by non-growing microplasmodia of Physarum polycephalum - Effects of metabolic intermediates and inhibitors

      FEMS MICROBIOLOGY LETTERS
    11. Eissner, G; Lindner, H; Konur, A; Kreutz, M; Andreesen, R; Holler, E
      Naive monocytes can trigger transendothelial migration of peripheral bloodcells through the induction of endothelial tumour necrosis factor-alpha

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    12. Wasch, R; Reisser, S; Hahn, J; Bertz, H; Engelhardt, M; Kunzmann, R; Veelken, H; Holler, E; Finke, J
      Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan andallogeneic transplantation

      BONE MARROW TRANSPLANTATION
    13. Holler, E; Roncarolo, MG; Hintermeier-Knabe, R; Eissner, G; Ertl, B; Schulz, U; Knabe, H; Kolb, HJ; Andreesen, R; Wilmanns, W
      Prognostic significance of increased IL-10 production in patients prior toallogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    14. Eissner, G; Kirchner, S; Lindner, H; Kolch, W; Janosch, P; Grell, M; Scheurich, P; Andreesen, R; Holler, E
      Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages

      JOURNAL OF IMMUNOLOGY
    15. Gasslmaier, B; Krell, CM; Seebach, D; Holler, E
      Synthetic substrates and inhibitors of beta-poly(L-malate)-hydrolase (polymalatase)

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    16. Kirchgatterer, A; Schwarz, CD; Holler, E; Punzengruber, C; Hartl, P; Eber, B
      Cardiac tamponade following acupuncture

      CHEST
    17. Salat, C; Holler, E; Kolb, HJ; Pihusch, R; Reinhardt, B; Penovici, M; Ledderose, G; Hiller, E
      The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker forthe diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation

      LEUKEMIA & LYMPHOMA
    18. Rathberger, K; Reisner, H; Willibald, B; Molitoris, HP; Holler, E
      Comparative synthesis and hydrolytic degradation of poly (L-malate) by myxomycetes and fungi

      MYCOLOGICAL RESEARCH
    19. Brandl, M; Grosse-Hovest, L; Holler, E; Kolb, HJ; Jung, G
      Bispecific antibody fragments with CD20 x CD28 specificity allow effectiveautologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma

      EXPERIMENTAL HEMATOLOGY
    20. Schleuning, M; Jager, G; Holler, E; Hill, W; Thomssen, C; Denzlinger, C; Lorenz, T; Ledderose, G; Wilmanns, W; Kolb, HJ
      Human parvovirus B19-associated disease in bone marrow transplantation

      INFECTION
    21. Lee, BS; Maurer, T; Kalbitzer, HR; Holler, E
      beta-Poly(L-malate) production by Physarum polycephalum - C-13 Nuclear magnetic resonance stwdies

      APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
    22. Lee, BS; Holler, E
      Effects of culture conditions on beta-poly(L-malate) production by Physarum polycephalum

      APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
    23. Padovan, CS; Bise, K; Hahn, J; Sostak, P; Holler, E; Kolb, HJ; Straube, A
      Angiitis of the central nervous system after allogeneic bone marrow transplantation?

      STROKE
    24. Willibald, B; Bildl, W; Lee, BS; Holler, E
      Is beta-poly(L-malate) synthesis catalysed by a combination of beta-L-malyl-AMP-ligase and beta-poly(L-malate) polymerase?

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    25. Hehlmann, R; Hochhaus, A; Kolb, HJ; Hasford, J; Gratwohl, A; Heimpel, H; Siegert, W; Finke, J; Ehninger, G; Holler, E; Berger, U; Pfirrmann, M; Muth, A; Zander, A; Fauser, AA; Heyll, A; Nerl, C; Hossfeld, DK; Loffler, H; Pralle, H; Queisser, W; Tobler, A
      Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure

      BLOOD
    26. Natarajan, G; Malathi, R; Holler, E
      Increased DNA binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (Carboplatin) in the presence of nucleophiles and human breastcancer MCF-7 cell cytoplasmic extracts: Activation theory revisited

      BIOCHEMICAL PHARMACOLOGY
    27. Fraunberger, P; Pfeiffer, N; Cremer, P; Holler, E; Nagel, D; Dehart, I; Thein, M; Walli, AK; Seidel, D
      Validation of an automated enzyme immunoassay for interleukin-6 for routine clinical use

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    28. DOERHOEFER S; KHODYREVA S; SAFRONOV IV; WLASSOFF WA; ANARBAEV R; LAVRIK OI; HOLLER E
      MOLECULAR CONSTITUENTS OF THE REPLICATION APPARATUS IN THE PLASMODIUMOF PHYSARUM-POLYCEPHALUM - IDENTIFICATION BY PHOTOAFFINITY-LABELING

      Microbiology
    29. MALATHI R; NATARAJAN G; HOLLER E
      HELIX-COIL TRANSITIONS IN DNA BY NOVEL PT(II) COMPLEXES - A PH MELTING STUDY

      Journal of biomolecular structure & dynamics
    30. PADOVAN CS; YOUSRY TA; SCHLEUNING M; HOLLER E; KOLB HJ; STRAUBE A
      NEUROLOGICAL AND NEURORADIOLOGICAL FINDINGS IN LONG-TERM SURVIVORS OFALLOGENEIC BONE-MARROW TRANSPLANTATION

      Annals of neurology
    31. KOLB HJ; MENZEL H; HOLLER E; SCHLEUNING M; LEDDEROSE G; WEISSINGER E; MITTERMULLER J
      ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA

      Bone marrow transplantation
    32. EISSNER G; MULTHOFF G; HOLLER E
      INFLUENCE OF BACTERIAL-ENDOTOXIN ON THE ALLOGENICITY OF HUMAN ENDOTHELIAL-CELLS

      Bone marrow transplantation
    33. HOLLER E; LEDDEROSE G; KNABE H; MUTH A; GUNTHER C; WILMANNS W; KOLB HJ
      ATG SEROTHERAPY DURING PRETRANSPLANT CONDITIONING IN UNRELATED DONOR BMT - DOSE-DEPENDENT MODULATION OF GVHD

      Bone marrow transplantation
    34. KOLB HJ; HOLLER E; LEDDEROSE G; SALAT C; MUTH A; GUNTHER C; SCHLEUNING M; MEMPEL W
      ADOPTIVE IMMUNOTHERAPY OF RELAPSE OF ACUTE-LEUKEMIA AND ADVANCED PHASE CML WITH BLOOD STEM-CELLS AND GM-CSF

      Bone marrow transplantation
    35. HEINEMANN V; VOGES K; HOLLER E; WACHHOLZ K; JEHN U; KOLB HJ
      REPRODUCIBLE PHARMACOKINETICS OF HIGH-DOSE BUSULFAN AND LOW INCIDENCEOF VOD AFTER DRUG APPLICATION TO FASTING PATIENTS

      Bone marrow transplantation
    36. GUENTHER C; HOLLER E; MUTH A; HUMANN M; LEDDEROSE G; HAHN J; WICK M; ROECKEN M; PLEWIG G; WILMANNS W; KOLB HJ
      INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    37. HEINEMANN V; STURM A; JEHN U; WACHHOLZ K; HOLLER E; KOLB HJ
      TISSUE CONCENTRATION AND ORGAN DISTRIBUTION OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME)

      Bone marrow transplantation
    38. HILL W; HOLLER E; SCHMIDT M; KOLB HJ
      LOW 5 YEARS INCIDENCE OF AVASCULAR NECROSIS OF BONE AFTER BONE-MARROWTRANSPLANTATION - ROLE OF CORTICOSTEROID REGIMENS FOR TREATMENT OF GVGD

      Bone marrow transplantation
    39. SALAT C; PIHUSCH R; FRAGIADAKI K; SCHMIDT E; HOLLER E; KOLB HJ; HILLER E
      COMPLICATIONS OF THE HEMOSTATIC SYSTEM IN BONE-MARROW TRANSPLANT RECIPIENTS - AN ANALYSIS OF 440 PATIENTS

      Bone marrow transplantation
    40. Holler, E; Kolb, HJ; Eissner, G; Wilmanns, W
      Cytokines in GvH and GvL

      BONE MARROW TRANSPLANTATION
    41. KARL M; HOLLER E
      MULTIPLE POLYPEPTIDES IMMUNOLOGICALLY RELATED TO BETA-POLY(L-MALATE) HYDROLASE (POLYMALATASE) IN THE PLASMODIUM OF THE SLIME-MOLD PHYSARUM-POLYCEPHALUM

      European journal of biochemistry
    42. BEHR TM; WORMANN B; GRATZ S; HOLLER E; KOLB HJ; HIDDEMANN W; GOLDENBERG DM; BECKER W
      36TH INTERNATIONAL ANNUAL-MEETING OF THE GERMAN-SOCIETY-FOR-NUCLEAR-MEDICINE

      Nuklearmedizin
    43. KOLB HJ; HOLLER E
      HEMATOPOIETIC TRANSPLANTATION - STATE-OF-THE-ART

      Stem cells
    44. HOLLER E; ERTL B; HINTERMEIERKNABE R; RONCAROLO MG; EISSNER G; MAYER F; FRAUNBERGER P; BEHRENDS U; PFANNES W; KOLB HJ; WILMANNS W
      INFLAMMATORY REACTIONS INDUCED BY PRETRANSPLANT CONDITIONING - AN ALTERNATIVE TARGET FOR MODULATION OF ACUTE GVHD AND COMPLICATIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Leukemia & lymphoma
    45. BEINERT T; HOLLER E; MERGENTHALER HG; DUBIEL M; FLEISCHHACKER M; BRUHN N; FLATH B; VOGELMEIER C; BEHR J; WOLFF C; KOLB HJ
      THE ROLE OF LUNG-FUNCTION MEASUREMENTS BEFORE ALLOGENIC BMT TO ANTICIPATE LONG-TERM LUNG FAILURE

      European journal of cancer
    46. BEHR TM; JUWEID ME; SHARKEY RM; HOLLER E; DUNN RM; KOLB HJ; WORMANN B; HIDDEMANN W; GOLDENBERG DM; BECKER W
      CD22 AS TARGET FOR RADIOIMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES OF B-CELL ORIGIN (NON-HODGKINS-LYMPHOMA, ACUTE LYMPHATIC-LEUKEMIA AND MACROGLOBULINEMIA)

      European journal of cancer
    47. SALAT C; HOLLER E; KOLB HJ; PIHUSCH R; REINHARDT B; HILLER E
      MARKERS OF ENDOTHELIAL-CELL PERTURBATION IN PATIENTS WITH AND WITHOUTACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION (BMT)

      Thrombosis and haemostasis
    48. SALAT C; HOLLER E; KOLB HJ; PIHUSCH R; REINHARDT B; HILLER E
      ENDOTHELIAL-CELL MARKERS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH AND WITHOUT ACUTE GRAFT-VERSUS-HOST DISEASE

      Bone marrow transplantation
    49. SALAT C; HOLLER E; WOLF C; KOLB HJ; REINHARDT B; PIHUSCH R; KRAMLING HJ; HEINEMANN V; HALLER M; HILLER E
      LABORATORY MARKERS OF VENOOCCLUSIVE DISEASE IN THE COURSE OF BONE-MARROW AND SUBSEQUENT LIVER-TRANSPLANTATION

      Bone marrow transplantation
    50. LINDNER H; HOLLER E; GERBITZ A; JOHNSON JP; BORNKAMM GW; EISSNER G
      INFLUENCE OF BACTERIAL-ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS IN-VITRO AND IN-VIVO - INTERLEUKIN-10 PROTECTS AGAINST TRANSENDOTHELIAL MIGRATION

      Transplantation
    51. KOLB HJ; GUNTHER W; SCHUMM M; HOLLER E; WILMANNS W; THIERFELDER S
      ADOPTIVE IMMUNOTHERAPY IN CANINE CHIMERAS

      Transplantation
    52. GASSLMAIER B; HOLLER E
      SPECIFICITY AND DIRECTION OF DEPOLYMERIZATION OF BETA-POLY(L-MALATE) CATALYZED BY POLYMALATASE FROM PHYSARUM-POLYCEPHALUM - FLUORESCENCE LABELING AT THE CARBOXY-TERMINUS OF BETA-POLY(L-MALATE)

      European journal of biochemistry
    53. EISSNER G; LINDNER H; REISBACH G; KLAUKE I; HOLLER E
      DIFFERENTIAL MODULATION OF IL-1-INDUCED ENDOTHELIAL ADHESION MOLECULES AND TRANSENDOTHELIAL MIGRATION OF GRANULOCYTES BY G-CSF

      British Journal of Haematology
    54. GUENTHER C; HOLLER E; MUTH A; LEDDEROSE G; HAHN J; THOMSSEN C; EICHHORN P; WICK M; ROECKEN M; PLEWIG G; WILMANNS W; KOLB HJ
      INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    55. KOLB HJ; MENZEL H; HOLLER E; VERDONCK L; BUNJES D; SCHATTENBERG A; APPERLEY JF; LJUNGMAN P; JACOBSEN N; FERRANT A
      DONOR CELL TRANSFUSION FOR THE TREATMENT OF RECURRENT LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    56. LINDNER H; HOLLER E; ERTL B; MULTHOFF G; SCHREGLMANN M; KLAUKE I; SCHULTZHECTOR S; EISSNER G
      PERIPHERAL-BLOOD MONONUCLEAR-CELLS INDUCE PROGRAMMED CELL-DEATH IN HUMAN ENDOTHELIAL-CELLS AND MAY PREVENT REPAIR - ROLE OF CYTOKINES

      Blood
    57. SALAT C; HOLLER E; KOLB HJ; REINHARDT B; PIHUSCH R; WILMANNS W; HILLER E
      PLASMINOGEN-ACTIVATOR INHIBITOR-1 CONFIRMS THE DIAGNOSIS OF HEPATIC VENOOCCLUSIVE DISEASE IN PATIENTS WITH HYPERBILIRUBINEMIA AFTER BONE-MARROW TRANSPLANTATION

      Blood
    58. SALAT C; BOEKSTEGERS P; HOLLER E; WERDAN K; REINHARDT B; FATEHMOGHADAM S; PIHUSCH R; KAUL M; BEINERT T; HILLER E
      HEMOSTATIC PARAMETERS IN SEPSIS PATIENTS TREATED WITH ANTI-TNF-ALPHA-MONOCLONAL ANTIBODIES

      Shock
    59. HAFNER F; HOLLER E; VONANGERER E
      EFFECT OF GROWTH-FACTORS ON ESTROGEN-RECEPTOR MEDIATED GENE-EXPRESSION

      Journal of steroid biochemistry and molecular biology
    60. ERTL B; ALBIEZ M; RUSTIGE E; KOLB HJ; WILMANNS W; HOLLER E
      DYSREGULATED MATURATION AND TNF-ALPHA-PRODUCTION OF MACROPHAGES IN AML-PATIENTS ADMITTED TO ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Journal of leukocyte biology
    61. SCHLEUNING M; JAGER G; HOLLER E; HILL W; THOMSSEN C; DENZLINGER C; LORENZ T; MUTH A; KOLB HJ
      THE INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION IN BONE-MARROW TRANSPLANTATION PATIENTS AND ITS IMPACT ON TRANSPLANT-RELATED MORBIDITY AND MORTALITY

      Experimental hematology
    62. FUNK JO; HOLLER E; KOHLHUBER F; UEFFING M; BORNKAMM GW; KIND P; EISSNER G
      PROTEIN-KINASE-C ACTIVATION IS INVOLVED IN ULTRAVIOLET-B IRRADIATION-INDUCED ENDOTHELIAL-CELL ICAM-1 UP-REGULATION AND LYMPHOCYTE-ENDOTHELIUM INTERACTION IN-VITRO

      Scandinavian journal of immunology
    63. KOLB HJ; MITTERMULLER J; HOLLER E; THALMEIER K; BARTRAM CR
      GRAFT-VERSUS-HOST REACTION SPARES NORMAL STEM-CELLS IN CHRONIC MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    64. SCHMIDT A; WINDISCH C; HOLLER E
      NUCLEAR ACCUMULATION AND HOMEOSTASIS OF THE UNUSUAL POLYMER BETA-POLY(L-MALATE) IN PLASMODIA OF PHYSARUM-POLYCEPHALUM

      European journal of cell biology
    65. SPULER S; YOUSRY T; SCHELLER A; VOLTZ R; HOLLER E; HARTMANN M; WICK M; HOHLFELD R
      MULTIPLE-SCLEROSIS - PROSPECTIVE ANALYSIS OF TNF-ALPHA AND 55 KDA TNFRECEPTOR IN CSF AND SERUM IN CORRELATION WITH CLINICAL AND MRI ACTIVITY

      Journal of neuroimmunology
    66. EISSNER G; LINDNER H; BEHRENDS U; KOLCH W; HIEKE A; KLAUKE I; BORNKAMM GW; HOLLER E
      INFLUENCE OF BACTERIAL-ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS IN-VITRO AND IN-VIVO - PROTECTIVE ROLE OF IL-10

      Transplantation
    67. HILL W; HOLLER E; SCHLEUNING M; SCHMID M; MUTH A; HILL C; KOLB HJ; WILMANNS W
      AVASCULAR NECROSIS OF BONE AFTER BONE-MARROW TRANSPLANTATION - INCIDENCE, CLINICAL FINDINGS AND RISK-FACTORS

      Blood
    68. LINDAUER E; HOLLER E
      CELLULAR-DISTRIBUTION AND CELLULAR-REACTIVITY OF PLATINUM(II) COMPLEXES

      Biochemical pharmacology
    69. NATARAJAN G; MALATHI R; HOLLER E
      HELIX-COIL TRANSITIONS IN DNA USING A PH VARIATION METHOD - CASE OF AMELTING PARADOX AS A FUNCTION OF IONIC-STRENGTH

      Analytical biochemistry
    70. HOLLER E; RININSLAND H
      TRENDS IN MANIPULATOR AND ROBOTIC DEVELOPMENT

      Minimally invasive therapy
    71. HOLLER E; RONCAROLO MG; HINTERMEIERKNABE R; ERTL B; RUSTIGE E; ALBIEZ M; KOLB HJ; WILMANNS W
      SYSTEMIC AND CELLULAR-RELEASE OF IL-10 IN HUMAN BMT

      European journal of cancer
    72. EISSNER G; KOHLHUBER F; GRELL M; SCHEURICH P; HIEKE A; BORNKAMM GW; HOLLER E
      BACTERIAL-ENDOTOXIN SENSITIZES HUMAN ENDOTHELIAL-CELLS AGAINST RADIATION-INDUCED PROGRAMMED CELL-DEATH THROUGH THE ACTION OF TRANSMEMBRANE TNF-ALPHA

      European journal of cancer
    73. SALAT C; HOLLER E; SCHLEUNING M; EISELE B; REINHARDT B; KOLB H; PIHUSCH R; DOMRATH R; HILLER E
      LEVELS OF THE TERMINAL COMPLEMENT COMPLEX, C3A-DESARG AND C1-INHIBITOR IN ADULT PATIENTS WITH CAPILLARY LEAK SYNDROME FOLLOWING BONE-MARROWTRANSPLANTATION

      Annals of hematology
    74. ZIPP F; WEBER F; HUBER S; SOTGIU S; CZLONKOWSKA A; HOLLER E; ALBERT E; WEISS EH; WEKERLE H; HOHLFELD R
      GENETIC-CONTROL OF MULTIPLE-SCLEROSIS - INCREASED PRODUCTION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR-ALPHA BY HLA-DR2(-CELLS() T)

      Annals of neurology
    75. SALAT C; FRAGIADAKI K; HOLLER E; KOLB HJ; PIHUSCH R; HILLER E
      HEMORRHAGIC AND THROMBOTIC COMPLICATIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION - AN ANALYSIS OF 105 PATIENTS

      Thrombosis and haemostasis
    76. EISSNER G; GRELL M; HIEKE A; UEFFING M; SCHEURICH P; BORNKAMM GW; HOLLER E
      ENDOTHELIAL-CELLS UNDERGO PROGRAMMED CELL-DEATH IN RESPONSE TO IONIZING-RADIATION AND ENDOTOXIN-ROLE OF TRANSMEMBRANE TNF-ALPHA

      Experimental hematology
    77. ACHHAMMER G; WINKLER A; ANGERER B; HOLLER E
      DNA-POLYMERASE-DELTA OF PHYSARUM-POLYCEPHALUM

      Current genetics
    78. DIDIC MM; COUFFIN F; HOLLER E; LAMPERIERE S; NEUSCHELER F; ROGIER J; DEVRIES M
      OPEN ENGINEERING AND OPERATIONAL ENVIRONMENT FOR CIMOSA

      Computers in industry
    79. EISSNER G; HOLLER E; KIND P; FUNK JO
      ROLE OF PROTEIN-KINASE-C IN ULTRAVIOLET-B IRRADIATION-INDUCED ICAM-1 EXPRESSION ON ENDOTHELIAL-CELLS

      Journal of investigative dermatology
    80. KORHERR C; ROTH M; HOLLER E
      POLY(BETA-L-MALATE) HYDROLASE FROM PLASMODIA OF PHYSARUM-POLYCEPHALUM

      Canadian journal of microbiology
    81. KOLB HJ; SCHATTENBERG A; GOLDMAN JM; HERTENSTEIN B; JACOBSEN N; ARCESE W; LJUNGMAN P; FERRANT A; VERDONCK L; NIEDERWIESER D; VANRHEE F; MITTERMUELLER J; DEWITTE T; HOLLER E; ANSARI H
      GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS

      Blood
    82. HOLLER E; KOLB HJ; MITTERMULLER J; KAUL M; LEDDEROSE G; DUELL T; SEEBER B; SCHLEUNING M; HINTERMEIERKNABE R; ERTL B; KEMPENI J; WILMANNS W
      MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F)

      Blood
    83. EISSNER G; KOHLHUBER F; GRELL M; UEFFING M; SCHEURICH P; HIEKE A; MULTHOFF G; BORNKAMM GW; HOLLER E
      CRITICAL INVOLVEMENT OF TRANSMEMBRANE TUMOR-NECROSIS-FACTOR-ALPHA IN ENDOTHELIAL PROGRAMMED CELL-DEATH MEDIATED BY IONIZING-RADIATION AND BACTERIAL-ENDOTOXIN

      Blood
    84. KOLB HJ; HOLLER E; KNABE H; LEDDEROSE G; MITTERMUELLER J; SCHLEUNING M; MAYER F; GOLDMANN SF; FISCHER M; LORENZ T; HILL W; SCHUH R
      CONDITIONING TREATMENT WITH ANTITHYMOCYTE GLOBULIN (ATG) MODIFIES GRAFT-VS-HOST DISEASE IN RECIPIENTS OF MARROW FROM UNRELATED DONORS

      Blood
    85. ANGERER B; HOLLER E
      LARGE COMPLEXES OF BETA-POLY(L-MALATE) WITH DNA-POLYMERASE-ALPHA, HISTONES, AND OTHER PROTEINS IN NUCLEI OF GROWING PLASMODIA OF PHYSARUM-POLYCEPHALUM

      Biochemistry
    86. WILLIBALD B; BOVES H; HOLLER E
      PREPARATIVE SYNTHESIS OF BETA-L-MALYL-COENZYME-A ASSISTED BY MALYL-COENZYME-A SYNTHETASE FROM PSEUDOMONAS AM1

      Analytical biochemistry
    87. BOEKSTEGERS P; WEIDENHOFER S; ZELL R; PILZ G; HOLLER E; ERTEL W; KAPSNER T; REDL H; SCHLAG G; KAUL M; KEMPENI J; STENZEL R; WERDAN K
      REPEATED ADMINISTRATION OF A F(AB')2 FRAGMENT OF AN ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - EFFECTS ON THE CARDIOVASCULAR-SYSTEM AND CYTOKINE LEVELS

      Shock
    88. BOEKSTEGERS P; WEIDENHOFER S; ZELL R; HOLLER E; KAPSNER T; REDL H; SCHLAG G; KAUL M; KEMPENI J; WERDAN K
      CHANGES IN SKELETAL-MUSCLE PO2 AFTER ADMINISTRATION OF ANTI-TNF-ALPHA-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - COMPARISON TO INTERLEUKIN-6SERUM LEVELS, APACHE-II, AND ELEBUTE SCORES

      Shock
    89. VONANGERER E; BIBERGER C; HOLLER E; KOOP R; LEICHTL S
      1-CARBAMOYLALKYL-2-PHENYLINDOLES - RELATIONSHIP BETWEEN SIDE-CHAIN STRUCTURE AND ESTROGEN ANTAGONISM

      Journal of steroid biochemistry and molecular biology
    90. SALAT C; HOLLER E; REINHARDT B; KOLB HJ; PIHUSCH R; NEUMEISTER P; HILLER E
      HYPERCOAGULABILITY IN PATIENTS WITH VENOO CCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION

      Medizinische Klinik
    91. EISSNER G; KOLCH W; MISCHAK H; BORNKAMM GW; HOLLER E
      DIFFERENTIAL ROLE OF PROTEIN-KINASE-C IN CYTOKINE-INDUCED LYMPHOCYTE-ENDOTHELIUM INTERACTION IN-VITRO

      Scandinavian journal of immunology
    92. SALAT C; HOLLER E; REINHARDT B; KOLB HJ; SEEBER B; LEDDEROSE G; MITTERMUELLER J; DUELL T; WILMANNS W; HILLER E
      PARAMETERS OF THE FIBRINOLYTIC SYSTEM IN PATIENTS UNDERGOING BMT - ELEVATION OF PAI-1 IN VENOOCCLUSIVE DISEASE

      Bone marrow transplantation
    93. MEYER T; KOOP R; VONANGERER E; SCHONENBERGER H; HOLLER E
      A RAPID LUCIFERASE TRANSFECTION ASSAY FOR TRANSCRIPTION ACTIVATION EFFECTS AND STABILITY CONTROL OF ESTROGENIC DRUGS IN CELL-CULTURES

      Journal of cancer research and clinical oncology
    94. BEHRENDS U; PETER RU; HINTERMEIERKNABE R; EISSNER G; HOLLER E; BORNKAMM GW; CAUGHMAN SW; DEGITZ K
      IONIZING-RADIATION INDUCES HUMAN INTERCELLULAR-ADHESION MOLECULE-1 IN-VITRO

      Journal of investigative dermatology
    95. DENZLINGER C; HOLLER E; REISBACH G; HILLER E; WILMANNS W
      GRANULOCYTE-COLONY-STIMULATING FACTOR INHIBITS THE ENDOGENOUS LEUKOTRIENE PRODUCTION IN TUMOR PATIENTS

      British Journal of Haematology
    96. SALAT C; HOLLER E; REINHARDT B; LEDDEROSE G; PIHUSCH R; KOLB HJ; HILLER E
      THROMBOMODULIN AND VON-WILLEBRAND-FACTOR IN PATIENTS WITH COMPLICATIONS OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION

      Thrombosis and haemostasis
    97. SALAT C; HOLLER E; REINHARDT B; DUELL T; MITTERMULLER H; KOLB HJ; HILLER E
      DISTURBANCES OF THE FIBRINOLYTIC SYSTEM AS A PATHOGENETIC FACTOR IN COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION

      Thrombosis and haemostasis
    98. HOLLER E
      CYTOKINES - THEIR ROLE AS EFFECTORS AND IN INDUCTION OF ACUTE GVHD

      Bone marrow transplantation
    99. KOLB HJ; HOLLER E
      PROCEEDINGS OF 19TH ANNUAL-MEETING OF THE EBMT AND 9TH MEETING OF THENURSES-GROUP - GARMISCH-PARTENKIRCHEN, GERMANY JANUARY 17-21, 1993 - FOREWORD

      Bone marrow transplantation
    100. HOLLER E; KOLB HJ; WILLMANNS W
      TREATMENT OF GVHD - TNF-ANTIBODIES AND RELATED ANTAGONISTS

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 13:07:56